Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Likun Chen

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Molecular Cancer Therapeutics|May 20, 2016
Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex VivoZhen Chen, Yifan Chen, Meng Xu, et al.
JAMA Network Open|February 8, 2023
Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non-Small Cell Lung Cancer in Patients With Brain Metastases: The GAP BRAIN Open-Label, Randomized, Multicenter, Phase 3 StudyXue Hou, Meichen Li, Guowu Wu, et al.
International Journal of Cancer|April 1, 2015
Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinomaXue Hou, Xuan Wu, Peiyu Huang, et al.
American Journal of Cancer Research|June 13, 2022
Analysis of the tumor microenvironment and mutation burden identifies prognostic features in thymic epithelial tumorsXue Hou, Suxia Lin, Yongdong Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 15, 2012
National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in ChinaCong Xue, Zhihuang Hu, Wei Jiang, et al.
Molecular Cancer|December 12, 2019
N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1Hongsheng Wang, Qianqian Deng, Ziyan Lv, et al.
Translational Oncology|January 13, 2017
Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement: Frequency, Clinical-Pathologic Characteristics, and Response to ALK InhibitorXinru Chen, Yu Zhang, Jiabin Lu, et al.
Molecular Cancer|August 12, 2023
Retraction Note: N6-methyladenosine induced mir-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1Hongsheng Wang, Qianqian Deng, Ziyan Lv, et al.
Journal of Hazardous Materials|May 15, 2018
GPER/Hippo-YAP signal is involved in Bisphenol S induced migration of triple negative breast cancer (TNBC) cellsQianqian Deng, Guanmin Jiang, Yingmin Wu, et al.
Cancer Research|April 27, 2023
N6-Methyladenosine Promotes Translation of VEGFA to Accelerate Angiogenesis in Lung CancerHaisheng Zhang, Jiawang Zhou, Jiexin Li, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Molecular Cancer Therapeutics|May 20, 2016
Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex VivoZhen Chen, Yifan Chen, Meng Xu, et al.
JAMA Network Open|February 8, 2023
Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non-Small Cell Lung Cancer in Patients With Brain Metastases: The GAP BRAIN Open-Label, Randomized, Multicenter, Phase 3 StudyXue Hou, Meichen Li, Guowu Wu, et al.
International Journal of Cancer|April 1, 2015
Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinomaXue Hou, Xuan Wu, Peiyu Huang, et al.
American Journal of Cancer Research|June 13, 2022
Analysis of the tumor microenvironment and mutation burden identifies prognostic features in thymic epithelial tumorsXue Hou, Suxia Lin, Yongdong Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 15, 2012
National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in ChinaCong Xue, Zhihuang Hu, Wei Jiang, et al.
Molecular Cancer|December 12, 2019
N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1Hongsheng Wang, Qianqian Deng, Ziyan Lv, et al.
Translational Oncology|January 13, 2017
Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement: Frequency, Clinical-Pathologic Characteristics, and Response to ALK InhibitorXinru Chen, Yu Zhang, Jiabin Lu, et al.
Molecular Cancer|August 12, 2023
Retraction Note: N6-methyladenosine induced mir-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1Hongsheng Wang, Qianqian Deng, Ziyan Lv, et al.
Journal of Hazardous Materials|May 15, 2018
GPER/Hippo-YAP signal is involved in Bisphenol S induced migration of triple negative breast cancer (TNBC) cellsQianqian Deng, Guanmin Jiang, Yingmin Wu, et al.
Cancer Research|April 27, 2023
N6-Methyladenosine Promotes Translation of VEGFA to Accelerate Angiogenesis in Lung CancerHaisheng Zhang, Jiawang Zhou, Jiexin Li, et al.
Pageof 13